280 related articles for article (PubMed ID: 15791506)
1. Fluoroquinolone prophylaxis in patients with neutropenia.
Zinner SH
Clin Infect Dis; 2005 Apr; 40(8):1094-5. PubMed ID: 15791506
[No Abstract] [Full Text] [Related]
2. Antibacterial prophylaxis in patients with cancer and neutropenia.
Ito JI; Tegtmeier BR; O'Donnell MR
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395829
[No Abstract] [Full Text] [Related]
3. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
4. The conundrum of fluoroquinolone prophylaxis.
Freifeld A; Sepkowitz K
Nat Clin Pract Oncol; 2006 Oct; 3(10):524-5. PubMed ID: 17019427
[No Abstract] [Full Text] [Related]
5. Antibacterial prophylaxis in patients with cancer and neutropenia.
Almyroudis NG; Segal BH
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
[No Abstract] [Full Text] [Related]
6. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
[TBL] [Abstract][Full Text] [Related]
7. [Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?].
Dubos F; Delebarre M; Lagrée M
Arch Pediatr; 2013 Nov; 20 Suppl 3():S90-3. PubMed ID: 24360309
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial prophylaxis in patients with cancer and neutropenia.
Freifeld AG; Sepkowitz KA; Martino P; Steven N; Billingham L; Cullen M; Baden LR
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16394310
[No Abstract] [Full Text] [Related]
9. Antibacterial prophylaxis in patients with cancer and neutropenia.
Pasqualotto AC; Rosa DD; Machado AL
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
[No Abstract] [Full Text] [Related]
10. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial prophylaxis in patients with cancer and neutropenia.
Eller P; Pechlaner C
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395828
[No Abstract] [Full Text] [Related]
12. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
Lo N; Cullen M
Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic antimicrobial agents and the importance of fitness.
Baden LR
N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
[No Abstract] [Full Text] [Related]
14. Antibacterial prophylaxis in patients with cancer and neutropenia.
Castagna L; Santoro A
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395831
[No Abstract] [Full Text] [Related]
15. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.
Kern WV; Steib-Bauert M; de With K; Reuter S; Bertz H; Frank U; von Baum H
J Antimicrob Chemother; 2005 Jan; 55(1):57-60. PubMed ID: 15574472
[TBL] [Abstract][Full Text] [Related]
16. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955.
Ng CF; Chan SY
J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610
[No Abstract] [Full Text] [Related]
17. Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2011 Apr; 15(4):e277-81. PubMed ID: 21324723
[TBL] [Abstract][Full Text] [Related]
18. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial prophylaxis in neutropenic patients.
Viscoli C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S60-5. PubMed ID: 17706926
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
